While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

在真实工程项目中，不使用 LangChain、LangGraph、CrewAI 等框架，纯用 Python + LLM API 手动实现 AI Agent 不仅完全可行，而且在许多场景下是更优选择。 Anthropic 官方明确建议开发者”从直接使用 ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

When writing or testing Python scripts, your terminal can quickly become cluttered with logs, debug messages, and outputs. A clean console not only improves readability but also helps you stay focused ...

Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top regulator of cancer drugs intervened during the review of the company’s lead asset ...

Despite a sharp drop in the previous session following the FDA rejection of its skin cancer drug RP1, Replimune (NASDAQ:REPL) shares bounced back on Wednesday even as multiple Wall Street analysts ...

Recent discussions on X about Replimune Group Inc. (REPL) have been ignited by the U.S. FDA's rejection of the company's lead drug, RP1, for melanoma treatment in combination therapy. Many users are ...

Multiple analysts have issued price targets for $REPL recently. We have seen 4 analysts offer price targets for $REPL in the last 6 months, with a median target of ...

The Python interpreter provides you with an environment for experimentation and observation—the Python shell, where we work in interactive mode. It’s a great way to get your feet wet. Figure 1: The ...

In this tutorial, we will discover how to harness the power of an advanced AI Agent, augmented with both Python execution and result-validation capabilities, to tackle complex computational tasks. By ...